GL1X · GenesisL1 explorer

Research workbench

Co-crystal structure of MDM2 with inhibitor {(2S,5R,6S)-6-(3- chlorophenyl)-5-(4-chlorophenyl)-4-[(2S)-1-hydroxybutan-2-yl]-3- oxomorpholin-2-YL}ACETIC acid

Analyse Co-crystal structure of MDM2 with inhibitor {(2S,5R,6S)-6-(3… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4JWR
Type
protein
Length
264 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
E3 ubiquitin-protein ligase MDM2
EC
6.3.2.-
UniProt
Q00987
Ligands
1MY
Pockets
5 · best druggability 0.63

Structure

x-ray diffraction · 1 distinct chain · 47% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B, CE3 ubiquitin-protein ligase MDM2 (EC 6.3.2.-)protein8847% helix, 18% strandQ00987

Ligands and binding sites

  • 1MY · {(2S,5R,6S)-6-(3-chlorophenyl)-5-(4-chlorophenyl)-4-[(2S)-1-hydroxybutan-2-yl]-3-oxomorpholin-2-yl}acetic acid · ligand · 3 copies · chains A, B, C

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12600.630.8134empty
22460.560.77251MY
31140.470.78161MY
41230.460.7934empty
51040.450.78161MY

Interfaces

3 interfaces between chains.

  • A–B · 593 Ų buried · 11 hydrogen bonds · protein-protein
  • A–C · 417 Ų buried · 10 hydrogen bonds · protein-protein
  • B–C · 129 Ų buried · 0 hydrogen bonds · protein-protein

Compared structures

  • 4JWR · Co-crystal structure of MDM2 with inhibitor {(2S,5R,6S)-6-(3-chlorophenyl)-5-(4-chlorophen… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.